GP-Act III Acquisition Corp-A Financials
This page shows GP-Act III Acquisition Corp-A (GPAT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
GP-Act III’s financials are driven by balance-sheet changes while operating activity remains too small to offset recurring cash burn.
Across the last two valid years, net income stayed positive, reaching$11.9M , while operating cash flow remained negative at-$372K . That split matters because cash shrank to$113K even as total assets still exceeded$309.4M , so the accounting gains were not funding everyday liquidity despite the larger asset base.
Liabilities exceeded assets by about
Administrative costs were essentially flat at roughly
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of GP-Act III Acquisition Corp-A's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
GP-Act III Acquisition Corp-A's current ratio of 0.30 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.
GP-Act III Acquisition Corp-A passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, GP-Act III Acquisition Corp-A generates $-0.03 in operating cash flow (-$372K OCF vs $11.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
GP-Act III Acquisition Corp-A reported $11.9M in net income in fiscal year 2025. This represents an increase of 37.1% from the prior year.
Cash & Balance Sheet
GP-Act III Acquisition Corp-A held $113K in cash against $0 in long-term debt as of fiscal year 2025.
Margins & Returns
Capital Allocation
GPAT Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $565K | N/A | $126K-10.6% | $141K-29.4% | $200K | N/A | $143K-19.1% | $177K |
| Operating Income | -$565K | N/A | -$126K+10.6% | -$141K+29.4% | -$200K | N/A | -$143K+19.1% | -$177K |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | $2.2M | N/A | $3.1M+4.1% | $3.0M+2.7% | $2.9M | N/A | $3.7M+106.5% | $1.8M |
| EPS (Diluted) | $0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
GPAT Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $312.1M+0.9% | $309.4M+0.9% | $306.5M+1.0% | $303.4M+1.0% | $300.5M+1.0% | $297.5M+1.1% | $294.1M+1.3% | $290.5M |
| Current Assets | $207K+9.8% | $188K-36.0% | $294K-35.2% | $454K-27.8% | $628K-6.9% | $675K-20.4% | $849K-15.4% | $1.0M |
| Cash & Equivalents | $119K+6.0% | $113K-22.5% | $145K-40.9% | $246K-34.6% | $377K-22.1% | $484K-5.8% | $514K-10.2% | $572K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $327.2M+1.0% | $323.9M+0.9% | $320.9M+1.0% | $317.7M+1.0% | $314.6M+1.0% | $311.4M+1.2% | $307.8M+1.2% | $304.1M |
| Current Liabilities | $1.2M+92.0% | $635K-3.3% | $656K-4.9% | $690K-6.6% | $739K+16.9% | $632K+13.0% | $559K-2.0% | $570K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$15.0M-3.9% | -$14.5M-0.6% | -$14.4M-0.9% | -$14.3M-1.0% | -$14.1M-1.4% | -$13.9M-1.3% | -$13.7M-1.1% | -$13.6M |
| Retained Earnings | -$15.0M-3.9% | -$14.5M-0.6% | -$14.4M-0.9% | -$14.3M-1.0% | -$14.1M-1.4% | -$13.9M-1.3% | -$13.7M-1.1% | -$13.6M |
GPAT Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$108K-1099.2% | $11K+110.7% | -$101K+22.6% | -$130K+14.3% | -$152K-407.6% | -$30K+48.6% | -$58K+87.0% | -$449K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | $0 | $0 | N/A |
| Financing Cash Flow | $115K+363.6% | -$44K | $0 | $0-100.0% | $45K | $0 | $0-100.0% | $288.4M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
GPAT Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 0.7% | N/A | 1.0%+0.0pp | 1.0%0.0pp | 1.0% | N/A | 1.2%+0.6pp | 0.6% |
| Current Ratio | 0.17-0.1 | 0.30-0.2 | 0.45-0.2 | 0.66-0.2 | 0.85-0.2 | 1.07-0.4 | 1.52-0.2 | 1.76 |
| Debt-to-Equity | -21.74+0.6 | -22.36-0.1 | -22.28-0.0 | -22.260.0 | -22.26+0.1 | -22.35+0.0 | -22.39-0.0 | -22.35 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$14.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.30), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Frequently Asked Questions
Is GP-Act III Acquisition Corp-A profitable?
Yes, GP-Act III Acquisition Corp-A (GPAT) reported a net income of $11.9M in fiscal year 2025.
What is GP-Act III Acquisition Corp-A's operating cash flow?
GP-Act III Acquisition Corp-A (GPAT) generated -$372K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are GP-Act III Acquisition Corp-A's total assets?
GP-Act III Acquisition Corp-A (GPAT) had $309.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What is GP-Act III Acquisition Corp-A's current ratio?
GP-Act III Acquisition Corp-A (GPAT) had a current ratio of 0.30 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is GP-Act III Acquisition Corp-A's debt-to-equity ratio?
GP-Act III Acquisition Corp-A (GPAT) had a debt-to-equity ratio of -22.36 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is GP-Act III Acquisition Corp-A's return on assets (ROA)?
GP-Act III Acquisition Corp-A (GPAT) had a return on assets of 3.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is GP-Act III Acquisition Corp-A's cash runway?
Based on fiscal year 2025 data, GP-Act III Acquisition Corp-A (GPAT) had $113K in cash against an annual operating cash burn of $372K. This gives an estimated cash runway of approximately 4 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is GP-Act III Acquisition Corp-A's debt-to-equity ratio negative or unusual?
GP-Act III Acquisition Corp-A (GPAT) has negative shareholder equity of -$14.5M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is GP-Act III Acquisition Corp-A's Piotroski F-Score?
GP-Act III Acquisition Corp-A (GPAT) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are GP-Act III Acquisition Corp-A's earnings high quality?
GP-Act III Acquisition Corp-A (GPAT) has an earnings quality ratio of -0.03x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is GP-Act III Acquisition Corp-A?
GP-Act III Acquisition Corp-A (GPAT) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.